Back to search

Article

Apolipoprotein B and Interleukin 1 Receptor Antagonist: Reversing the Risk of Coronary Heart Disease

2023-04-21

Abstract excerpt

<h4>Background</h4> Epidemiological evidence for the link of interleukin 1 (IL-1) and its inhibition with coronary heart disease (CHD) remains controversial. We aim to investigate the cardiovascular effects of IL-1 receptor antagonist (IL-1Ra) and underlying mechanisms, as well as the potential interaction with lifestyle factors. <h4>Methods</h4> A comprehensive multivariable Mendelian randomization study was pe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bfd64f2d-6d1f-57e1-86dd-80f9ecd2070a
DOI
10.1101/2023.04.19.537591
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Apolipoprotein B and Interleukin 1 Receptor Antagonist: Reversing the Risk of Coronary Heart DiseaseDOI 10.1101/2023.04.19.537591
The Causal Role of Apolipoprotein B/A1 Ratio in Coronary Heart Disease and Ischemic Stroke: A Mendelian Randomization StudySemantic proximity
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis.Semantic proximity
A potentially underestimated predictor of coronary artery disease risk: The ApoB/ApoA1 ratioSemantic proximity
Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes.Semantic proximity
Interleukin 1 receptor antagonist polymorphisms are associated with the risk of developing acute coronary syndrome in Mexicans.Semantic proximity
Exploring the therapeutic potential of interleukin-6 receptor blockade in cardiovascular disease treatment through Mendelian randomization.Semantic proximity
Circulating Cytokines Mediate the Protective Effect of Physical Activity on Cardiovascular Diseases: A Mendelian Randomization Mediation AnalysisSemantic proximity
Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study.Semantic proximity
Genetic effects of inflammatory cytokines on coronary artery disease and myocardial infarction and the mediating roles of lipid traits.Semantic proximity
Association of interleukin-6 circulating levels with coronary artery disease: a meta-analysis implementing mendelian randomization approach.Semantic proximity
[Associations of interleukin gene IL1B-511C/T and IL1RN+8006T/C polymorphisms with coronary artery disease in Chinese population: meta-analysis].Semantic proximity
Childhood Adiposity and Risk of Major Clinical Heart Diseases in Adulthood: A Mendelian Randomization Study.Semantic proximity
Select a neighboring publication to make it the new centre.